MRBK
Meridian Corporation
MRBK trails on the overall score without a compensating advantage in the available component scores.
MS
Morgan Stanley
MS has the edge over MRBK overall, supported by stronger modeled upside and stronger fundamentals.
MRBK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MRBK's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MRBK.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
MRBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $10.15 | -39% |
| Fair | 8.2x | $13.80 | -16% |
| Current | 9.8x | $16.51 | — |
| Forward | 9.8x | $16.51 | — |
| Expensive | 10x | $17.49 | +5.9% |
Historical ranges are pointers, not guarantees.
MRBK has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
MRBK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect MRBK's earnings and profitability to decline, with its revenue holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over MRBK on the outlook, with more favorable valuation and earnings expectations.
MRBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.69 | 0% |
| Q3 2026 | $1.69 | -4.5% |
| Q2 2026 | $1.84 | +14% |
| Q1 2026 | $1.85 | +30% |
| Q4 2025 | $1.89 | +30% |
| Q3 2025 | $1.77 | +74% |
| Q2 2025 | $1.61 | +69% |
| Q1 2025 | $1.42 | +34% |
| Q4 2024 | $1.45 | +25% |
MRBK's earnings per share have fallen from their peak: $1.69 over the past year, against $2.96 in mid-2021.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over MRBK on earnings, with more consistent year-over-year improvement.
MRBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30.1M | -8.9% |
| Q2 2026 | $32.7M | +0.7% |
| Q1 2026 | $30.2M | +12% |
| Q4 2025 | $34.2M | +5.1% |
| Q3 2025 | $33.1M | +14% |
| Q2 2025 | $32.4M | +24% |
| Q1 2025 | $27.1M | +10% |
| Q4 2024 | $32.6M | +30% |
MRBK's revenue fell from its 2020 peak and has held roughly level since: $30M last quarter, down 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -6.4 points |
| Q2 2026 | 23% | +0.4 points |
| Q1 2026 | 8.6% | -3 points |
| Q4 2025 | 27% | +3.8 points |
| Q3 2025 | 26% | +4.8 points |
| Q2 2025 | 22% | +5.6 points |
| Q1 2025 | 12% | -2.8 points |
| Q4 2024 | 23% | +20 points |
MRBK's operating margin was 20% last quarter, down 6.4 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over MRBK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over MRBK on profitability, with a higher operating margin.
MRBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $12.4M | -48% |
| Q2 2026 | -$1.4M | +$11.3M |
| Q1 2026 | $2.6M | -85% |
| Q4 2025 | -$6.6M | -$5.5M |
| Q3 2025 | $24M | -27% |
| Q2 2025 | -$12.7M | +$6.6M |
| Q1 2025 | $17.9M | +$21.5M |
| Q4 2024 | -$1.1M | -115% |
MRBK has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
MRBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +48K shares |
| 1 year | +5.9% | +682K shares |
| 3 years | +7.6% | +859K shares |
| 5 years | -1.9% | -240K shares |
MRBK has 12M diluted shares, up 5.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $1,000 |
| Q2 2023 | $1.6M |
| Q1 2023 | $2.7M |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over MRBK on shareholder dilution, with a more favorable share count trend.
MRBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | 10.1x | High |
| Q4 2019 | 9.6x | High |
MRBK's net debt is about 10 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like MRBK.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
MRBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.4 | Neutral |
| Stochastic | 15.5 | Oversold |
MRBK's weekly RSI is 32 (neutral) and its Stochastic is 16 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
MRBK PE vs Financial Services Sector
| Metric | MRBK | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 13x | 25% below |
| PE % | 71 | 63 | 8 pts above |
MRBK has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
MRBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.2 | 9.4% below |
| 20 week MA | $19.1 | 14% below |
| 50 week MA | $18.9 | 13% below |
| 100 week MA | $16.7 | 1% below |
| 200 week MA | $14.2 | 16% above |
MRBK has fallen below most of its moving averages, though it's still 16% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over MRBK on trend strength, trading above more of its moving averages.
MRBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.88 | $10.4 | +5.1% |
| 2021 | $10.4 | $17.7 | +70% |
| 2022 | $17.7 | $15.0 | -15% |
| 2023 | $15.0 | $13.9 | -7.5% |
| 2024 | $13.9 | $13.4 | -3.6% |
| 2025 | $13.4 | $17.6 | +31% |
| 2026 YTD | $17.6 | $16.5 | -6.3% |
MRBK has finished lower in three of the last six years. It's down 6.3% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over MRBK on returns for 2026, with the stronger performance.